{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:10:34Z","timestamp":1793214634270,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non-infectious anterior uveitis (AU) is a potentially sight threatening inflammatory condition. The current gold standard for treatment is topical steroids, but low ocular bioavailability and compliance issues with the intensive dosing regimen limit the efficacy of this treatment. Liposomes as a drug delivery system may help to overcome these problems. We studied the efficacy of a PEG-liposomal formulation of liposomal steroids, administered as a single subconjunctival dose, in the treatment of experimental uveitis in rabbit eyes. Rabbits that received subconjunctival liposomal triamcinolone acetonide phosphate (LTAP) or liposomal prednisolone phosphate (LPP) had significantly lower mean inflammatory scores than untreated controls on Day 4 after induction of uveitis (LPP vs controls, p\u2009=\u20090.049) and 8 (LPP vs controls, p\u2009=\u20090.007; LTAP vs controls, p\u2009=\u20090.019), and lower scores than rabbits given topical PredForte1% 4 times a day on Day 8 (p\u2009=\u20090.03). After antigen rechallenge, the subconjunctival liposomal steroid groups continued to have greater suppression of inflammation than untreated controls on Day 11 (p\u2009=\u20090.02). Localization of liposomes in inflamed ocular tissue was confirmed by histology and immunostaining, and persisted in the eye for at least one month. Our study demonstrates that a single subconjunctival injection of liposomal steroids induces effective and sustained anti-inflammatory action.<\/jats:p>","DOI":"10.1038\/s41598-018-24545-2","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T13:54:28Z","timestamp":1524232468000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0935-2016","authenticated-orcid":false,"given":"Chee Wai","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Czarny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josbert M.","family":"Metselaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candice","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si Rui","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amutha Veluchamy","family":"Barathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina T.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"key":"24545_CR1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1076\/ocii.10.4.263.15592","volume":"10","author":"JH-M Chang","year":"2002","unstructured":"Chang, J. H.-M. & Wakefield, D. Uveitis: a global perspective. Ocul. Immunol. Inflamm. 10, 263\u2013279 (2002).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"24545_CR2","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1136\/bjo.84.7.706","volume":"84","author":"L Dandona","year":"2000","unstructured":"Dandona, L., Dandona, R., John, R. K., McCarty, C. A. & Rao, G. N. Population based assessment of uveitis in an urban population in southern India. Br. J. Ophthalmol. 84, 706\u2013709 (2000).","journal-title":"Br. J. Ophthalmol."},{"key":"24545_CR3","doi-asserted-by":"crossref","unstructured":"Gritz, D. C. & Wong, I. G. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 111, 491\u2013500; discussion 500 (2004).","DOI":"10.1016\/j.ophtha.2003.06.014"},{"key":"24545_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1600-0420.1997.tb00255.x","volume":"75","author":"T P\u00e4iv\u00f6nsalo-Hietanen","year":"1997","unstructured":"P\u00e4iv\u00f6nsalo-Hietanen, T., Tuominen, J., Vaahtoranta-Lehtonen, H. & Saari, K. M. Incidence and prevalence of different uveitis entities in Finland. Acta Ophthalmol. 75, 76\u201381 (1997).","journal-title":"Acta Ophthalmol."},{"key":"24545_CR5","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3109\/09273949409057073","volume":"2","author":"VT Tran","year":"1994","unstructured":"Tran, V. T., Auer, C., Guex-Crosier, Y., Pittet, N. & Herbort, C. P. Epidemiology of uveitis in Switzerland. Ocul. Immunol. Inflamm. 2, 169\u2013176 (1994).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"24545_CR6","doi-asserted-by":"publisher","first-page":"705","DOI":"10.5301\/ejo.5000278","volume":"23","author":"E Miserocchi","year":"2013","unstructured":"Miserocchi, E., Fogliato, G., Modorati, G. & Bandello, F. Review on the worldwide epidemiology of uveitis. Eur. J. Ophthalmol. 23, 705\u2013717 (2013).","journal-title":"Eur. J. Ophthalmol."},{"key":"24545_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.preteyeres.2011.06.005","volume":"30","author":"MD de Smet","year":"2011","unstructured":"de Smet, M. D. et al. Understanding uveitis: the impact of research on visual outcomes. Prog. Retin. Eye Res. 30, 452\u2013470 (2011).","journal-title":"Prog. Retin. Eye Res."},{"key":"24545_CR8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000336676","volume":"51","author":"P LeHoang","year":"2012","unstructured":"LeHoang, P. The gold standard of noninfectious uveitis: corticosteroids. Dev. Ophthalmol. 51, 7\u201328 (2012).","journal-title":"Dev. Ophthalmol."},{"key":"24545_CR9","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1517\/17425247.2014.938045","volume":"11","author":"PK Suresh","year":"2014","unstructured":"Suresh, P. K. & Sah, A. K. Nanocarriers for ocular delivery for possible benefits in the treatment of anterior uveitis: focus on current paradigms and future directions. Expert Opin. Drug Deliv. 11, 1747\u20131768 (2014).","journal-title":"Expert Opin. Drug Deliv."},{"key":"24545_CR10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0039-6257(93)90141-S","volume":"37","author":"A Urtti","year":"1993","unstructured":"Urtti, A. & Salminen, L. Minimizing systemic absorption of topically administered ophthalmic drugs. Surv. Ophthalmol. 37, 435\u2013456 (1993).","journal-title":"Surv. Ophthalmol."},{"key":"24545_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1089\/jop.2012.0208","volume":"29","author":"Y Athanasiadis","year":"2013","unstructured":"Athanasiadis, Y., Tsatsos, M., Sharma, A. & Hossain, P. Subconjunctival triamcinolone acetonide in the management of ocular inflammatory disease. J. Ocul. Pharmacol. Ther. 29, 516\u2013522 (2013).","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"24545_CR12","doi-asserted-by":"publisher","first-page":"e97555","DOI":"10.1371\/journal.pone.0097555","volume":"9","author":"M Ang","year":"2014","unstructured":"Ang, M. et al. Evaluation of a prednisolone acetate-loaded subconjunctival implant for the treatment of recurrent uveitis in a rabbit model. PLoS One 9, e97555 (2014).","journal-title":"PLoS One"},{"key":"24545_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.apsb.2016.09.001","volume":"7","author":"Y Weng","year":"2017","unstructured":"Weng, Y. et al. Nanotechnology-based strategies for treatment of ocular disease. Acta Pharm Sin B 7, 281\u2013291 (2017).","journal-title":"Acta Pharm Sin B"},{"key":"24545_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.colsurfb.2011.06.025","volume":"88","author":"J Ara\u00fajo","year":"2011","unstructured":"Ara\u00fajo, J., Nikolic, S., Egea, M. A., Souto, E. B. & Garcia, M. L. Nanostructured lipid carriers for triamcinolone acetonide delivery to the posterior segment of the eye. Colloids Surf. B Biointerfaces 88, 150\u2013157 (2011).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"24545_CR15","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3109\/10717544.2015.1129475","volume":"23","author":"R Agarwal","year":"2016","unstructured":"Agarwal, R. et al. Liposomes in topical ophthalmic drug delivery: an update. Drug Deliv. 23, 1075\u20131091 (2016).","journal-title":"Drug Deliv."},{"key":"24545_CR16","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.jconrel.2012.01.019","volume":"161","author":"A Bochot","year":"2012","unstructured":"Bochot, A. & Fattal, E. Liposomes for intravitreal drug delivery: a state of the art. J. Control. Release 161, 628\u2013634 (2012).","journal-title":"J. Control. Release"},{"key":"24545_CR17","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.nano.2012.03.004","volume":"9","author":"JM Kaiser","year":"2013","unstructured":"Kaiser, J. M. et al. Nanoliposomal minocycline for ocular drug delivery. Nanomedicine 9, 130\u2013140 (2013).","journal-title":"Nanomedicine"},{"key":"24545_CR18","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1167\/iovs.06-1305","volume":"48","author":"L Lajavardi","year":"2007","unstructured":"Lajavardi, L. et al. Downregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal Peptide encapsulated in liposomes. Invest. Ophthalmol. Vis. Sci. 48, 3230\u20133238 (2007).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"24545_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jconrel.2009.05.033","volume":"139","author":"L Lajavardi","year":"2009","unstructured":"Lajavardi, L. et al. New formulation of vasoactive intestinal peptide using liposomes in hyaluronic acid gel for uveitis. J. Control. Release 139, 22\u201330 (2009).","journal-title":"J. Control. Release"},{"key":"24545_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1006\/exer.2001.1016","volume":"73","author":"H Baatz","year":"2001","unstructured":"Baatz, H., Puchta, J., Reszka, R. & Pleyer, U. Macrophage depletion prevents leukocyte adhesion and disease induction in experimental melanin-protein induced uveitis. Exp. Eye Res. 73, 101\u2013109 (2001).","journal-title":"Exp. Eye Res."},{"key":"24545_CR21","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1006\/exer.1997.0396","volume":"65","author":"RM Broekhuyse","year":"1997","unstructured":"Broekhuyse, R. M., Huitinga, I., Kuhlmann, E. D., Van Rooijen, N. & Winkens, H. J. Differential Effect of Macrophage Depletion on Two Forms of Experimental Uveitis Evoked by Pigment Epithelial Membrane Protein (EAPU), and by Melanin-Protein (EMIU). Exp. Eye Res. 65, 841\u2013848 (1997).","journal-title":"Exp. Eye Res."},{"key":"24545_CR22","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/S0165-5728(98)00042-3","volume":"86","author":"I Pouvreau","year":"1998","unstructured":"Pouvreau, I. et al. Effect of macrophage depletion by liposomes containing dichloromethylene-diphosphonate on endotoxin-induced uveitis. J. Neuroimmunol. 86, 171\u2013181 (1998).","journal-title":"J. Neuroimmunol."},{"key":"24545_CR23","doi-asserted-by":"crossref","unstructured":"Puchta, J., Pleyer, U. & Reszka, R. Macrophage depletion inhibits leukocyte recruitment in experimental melanin-induced uveitis (EMIU).: Zeitschrift der Deutschen \u2026 (2002).","DOI":"10.1007\/s003470100516"},{"key":"24545_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1076\/ocii.6.1.51.8079","volume":"6","author":"SM Whitcup","year":"1998","unstructured":"Whitcup, S. M. et al. Topical liposome-encapsulated FK506 for the treatment of endotoxin-induced uveitis. Ocul. Immunol. Inflamm. 6, 51\u201356 (1998).","journal-title":"Ocul. Immunol. Inflamm."},{"key":"24545_CR25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/138920012798356934","volume":"13","author":"P Milla","year":"2012","unstructured":"Milla, P., Dosio, F. & Cattel, L. PEGylation of proteins and liposomes: a powerful and flexible strategy to improve the drug delivery. Curr. Drug Metab. 13, 105\u2013119 (2012).","journal-title":"Curr. Drug Metab."},{"key":"24545_CR26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/ard.2003.009944","volume":"63","author":"JM Metselaar","year":"2004","unstructured":"Metselaar, J. M. et al. Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis. Ann. Rheum. Dis. 63, 348\u2013353 (2004).","journal-title":"Ann. Rheum. Dis."},{"key":"24545_CR27","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1002\/art.11140","volume":"48","author":"JM Metselaar","year":"2003","unstructured":"Metselaar, J. M., Wauben, M. H. M., Wagenaar-Hilbers, J. P. A., Boerman, O. C. & Storm, G. Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes. Arthritis Rheum. 48, 2059\u20132066 (2003).","journal-title":"Arthritis Rheum."},{"key":"24545_CR28","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jconrel.2016.12.042","volume":"247","author":"IE Allijn","year":"2017","unstructured":"Allijn, I. E. et al. Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction. J. Control. Release 247, 127\u2013133 (2017).","journal-title":"J. Control. Release"},{"key":"24545_CR29","doi-asserted-by":"publisher","first-page":"e54016","DOI":"10.1371\/journal.pone.0054016","volume":"8","author":"W Hofkens","year":"2013","unstructured":"Hofkens, W., Schelbergen, R., Storm, G., van den Berg, W. B. & van Lent, P. L. Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation. PLoS One 8, e54016 (2013).","journal-title":"PLoS One"},{"key":"24545_CR30","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1021\/mp2000742","volume":"8","author":"JM van den Hoven","year":"2011","unstructured":"van den Hoven, J. M. et al. Liposomal drug formulations in the treatment of rheumatoid arthritis. Mol. Pharm. 8, 1002\u20131015 (2011).","journal-title":"Mol. Pharm."},{"key":"24545_CR31","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.nano.2015.02.020","volume":"11","author":"ME Lobatto","year":"2015","unstructured":"Lobatto, M. E. et al. Pharmaceutical development and preclinical evaluation of a GMP-grade anti-inflammatory nanotherapy. Nanomedicine 11, 1133\u20131140 (2015).","journal-title":"Nanomedicine"},{"key":"24545_CR32","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1167\/iovs.10-5939","volume":"52","author":"CR Ghosn","year":"2011","unstructured":"Ghosn, C. R. et al. Treatment of experimental anterior and intermediate uveitis by a dexamethasone intravitreal implant. Invest. Ophthalmol. Vis. Sci. 52, 2917\u20132923 (2011).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"24545_CR33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/S0161-6420(85)34001-0","volume":"92","author":"RB Nussenblatt","year":"1985","unstructured":"Nussenblatt, R. B., Palestine, A. G., Chan, C. C. & Roberge, F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology 92, 467\u2013471 (1985).","journal-title":"Ophthalmology"},{"key":"24545_CR34","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0002-9394(14)74235-7","volume":"103","author":"E Bloch-Michel","year":"1987","unstructured":"Bloch-Michel, E. & Nussenblatt, R. B. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am. J. Ophthalmol. 103, 234\u2013235 (1987).","journal-title":"Am. J. Ophthalmol."},{"key":"24545_CR35","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijpharm.2010.06.015","volume":"396","author":"L Gan","year":"2010","unstructured":"Gan, L. et al. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: Improving preocular retention and ocular bioavailability. Int. J. Pharm. 396, 179\u2013187 (2010).","journal-title":"Int. J. Pharm."},{"key":"24545_CR36","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00106-013-2736-x","volume":"61","author":"B Hofauer","year":"2013","unstructured":"Hofauer, B., Bas, M., Manour, N. & Knopf, A. Liposomal local therapy as treatment for sicca symptoms in patients with primary Sj\u00f6gren\u2019s syndrome. HNO 61, 921\u2013927 (2013).","journal-title":"HNO"},{"key":"24545_CR37","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00405-011-1696-6","volume":"269","author":"M B\u00f6hm","year":"2012","unstructured":"B\u00f6hm, M., Avgitidou, G., El Hassan, E. & M\u00f6sges, R. Liposomes: a new non-pharmacological therapy concept for seasonal-allergic-rhinoconjunctivitis. Eur. Arch. Otorhinolaryngol. 269, 495\u2013502 (2012).","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"24545_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/BF00161017","volume":"82","author":"M D\u00edaz-Llopis","year":"1992","unstructured":"D\u00edaz-Llopis, M. et al. Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patients. Eperimental toxicity and pharmacokinetics, and clinical trial. Doc. Ophthalmol. 82, 297\u2013305 (1992).","journal-title":"Doc. Ophthalmol."},{"key":"24545_CR39","first-page":"163","volume":"17","author":"R Jones 3rd","year":"2006","unstructured":"Jones, R. 3rd & Rhee, D. J. Corticosteroid-induced ocular hypertension and glaucoma: a brief review and update of the literature. Curr. Opin. Ophthalmol. 17, 163\u2013167 (2006).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"24545_CR40","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.exer.2008.10.004","volume":"88","author":"AF Clark","year":"2009","unstructured":"Clark, A. F. & Wordinger, R. J. The role of steroids in outflow resistance. Exp. Eye Res. 88, 752\u2013759 (2009).","journal-title":"Exp. Eye Res."},{"key":"24545_CR41","doi-asserted-by":"publisher","first-page":"49","DOI":"10.15171\/bi.2016.07","volume":"6","author":"J Barar","year":"2016","unstructured":"Barar, J., Aghanejad, A., Fathi, M. & Omidi, Y. Advanced drug delivery and targeting technologies for the ocular diseases. Bioimpacts 6, 49\u201367 (2016).","journal-title":"Bioimpacts"},{"key":"24545_CR42","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1517\/17425247.5.5.567","volume":"5","author":"J Barar","year":"2008","unstructured":"Barar, J., Javadzadeh, A. R. & Omidi, Y. Ocular novel drug delivery: impacts of membranes and barriers. Expert Opin. Drug Deliv. 5, 567\u2013581 (2008).","journal-title":"Expert Opin. Drug Deliv."},{"key":"24545_CR43","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/0304-4165(88)90049-9","volume":"965","author":"G Storm","year":"1988","unstructured":"Storm, G., Steerenberg, P. A., Emmen, F., van Borssum Waalkes, M. & Crommelin, D. J. Release of doxorubicin from peritoneal macrophages exposed in vivo to doxorubicin-containing liposomes. Biochim. Biophys. Acta 965, 136\u2013145 (1988).","journal-title":"Biochim. Biophys. Acta"},{"key":"24545_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3109\/08982108909035991","volume":"1","author":"G Storm","year":"1989","unstructured":"Storm, G., Regts, J., Beijnen, J. H. & Roerdink, F. H. Processing of Doxorubicin-Containing Liposomes by Liver Macrophages in Vitro. J. Liposome Res. 1, 195\u2013210 (1989).","journal-title":"J. Liposome Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24545-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24545-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24545-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T04:44:18Z","timestamp":1671597858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-24545-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["24545"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-24545-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]},"assertion":[{"value":"13 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Josbert M. Metselaar is affiliated with the company Enceladus Pharmaceuticals (Amsterdam, The Netherlands). None of the other authors have any conflict of interests","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"6604"}}